Gastrointestinal toxicities of immune checkpoint inhibitors: a multicenter retrospective analysis

BACKGROUND: Immune checkpoint inhibitors are monoclonal antibodies that augment immune cell function and are used to treat malignancy. However, they may cause proinflammatory adverse events. This study investigated gastrointestinal (GI) adverse events associated with specific immune checkpoint inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Shieh, Christine, Chalikonda, Divya, Block, Peter, Shinn, Brianna, Kistler, C. Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774670/
https://www.ncbi.nlm.nih.gov/pubmed/33414621
http://dx.doi.org/10.20524/aog.2020.0552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7774670/
https://www.ncbi.nlm.nih.gov/pubmed/33414621
http://dx.doi.org/10.20524/aog.2020.0552

Ejemplares similares